PriceTargets.com logo

Thorne HealthTech - THRN Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $6.83
  • Forecasted Upside: 36.12%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$5.02 As of 03/24/2023 01:00 AM ET
▲ +0.32 (6.81%)

This chart shows the closing price for THRN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Thorne HealthTech Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for THRN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for THRN

Analyst Price Target is $6.83
▲ +36.12% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Thorne HealthTech in the last 3 months. The average price target is $6.83, with a high forecast of $8.00 and a low forecast of $5.50. The average price target represents a 36.12% upside from the last price of $5.02.

This chart shows the closing price for THRN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 polled investment analysts is to buy stock in Thorne HealthTech.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/2/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/31/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2023

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/17/2022Canaccord Genuity GroupInitiated CoverageBuy$5.50Low
11/16/2022Canaccord Genuity GroupInitiated CoverageBuy$5.50Low
11/16/2022Evercore ISILower Target$8.00Low
11/11/2022Royal Bank of CanadaLower TargetOutperform$8.00 ➝ $6.00Low
8/11/2022CowenLower TargetOutperform$12.00 ➝ $8.00Low
8/11/2022CowenLower Target$12.00 ➝ $8.00Low
8/11/2022Royal Bank of CanadaLower TargetOutperform$11.00 ➝ $8.00Low
10/18/2021Bank of AmericaInitiated CoverageBuy$11.00Low
10/18/2021Evercore ISIInitiated CoverageOutperform$13.00Medium
10/18/2021CowenInitiated CoverageOutperform$11.00Medium
10/18/2021Royal Bank of CanadaInitiated CoverageOutperform$11.00Medium
(Data available from 3/26/2018 forward)

News Sentiment Rating

1.52 (Strong Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2022
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2022
  • 2 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
11/26/2022
  • 3 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2023
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2023

Current Sentiment

  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

Thorne HealthTech logo
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.
Read More

Today's Range

Now: $5.02
Low: $4.70
High: $5.28

50 Day Range

MA: $4.48
Low: $3.54
High: $5.02

52 Week Range

Now: $5.02
Low: $3.41
High: $7.38

Volume

72,906 shs

Average Volume

49,154 shs

Market Capitalization

$265.26 million

P/E Ratio

83.67

Dividend Yield

N/A

Beta

0.99

Frequently Asked Questions

What sell-side analysts currently cover shares of Thorne HealthTech?

The following Wall Street sell-side analysts have issued reports on Thorne HealthTech in the last year: Canaccord Genuity Group Inc., Cowen Inc, Cowen Inc., Evercore ISI, Royal Bank of Canada, and TheStreet.
View the latest analyst ratings for THRN.

What is the current price target for Thorne HealthTech?

6 Wall Street analysts have set twelve-month price targets for Thorne HealthTech in the last year. Their average twelve-month price target is $6.83, suggesting a possible upside of 36.1%. Evercore ISI has the highest price target set, predicting THRN will reach $8.00 in the next twelve months. Canaccord Genuity Group Inc. has the lowest price target set, forecasting a price of $5.50 for Thorne HealthTech in the next year.
View the latest price targets for THRN.

What is the current consensus analyst rating for Thorne HealthTech?

Thorne HealthTech currently has 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe THRN will outperform the market and that investors should add to their positions of Thorne HealthTech.
View the latest ratings for THRN.

What other companies compete with Thorne HealthTech?

Other companies that are similar to Thorne HealthTech include Adicet Bio, Organogenesis, Acrivon Therapeutics, Kinnate Biopharma and Kezar Life Sciences. Learn More about companies similar to Thorne HealthTech.

How do I contact Thorne HealthTech's investor relations team?

Thorne HealthTech's physical mailing address is 152 W. 57th Street, New York NY, 10019. The company's listed phone number is 929-251-6321 and its investor relations email address is [email protected] The official website for Thorne HealthTech is www.thorne.com. Learn More about contacing Thorne HealthTech investor relations.